Absci/$ABSI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Absci
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Ticker
$ABSI
Sector
Primary listing
Employees
140
Headquarters
Website
Absci Metrics
BasicAdvanced
$1.3bn
-
-$0.82
2.38
-
Price and volume
Market cap
$1.3bn
Beta
2.38
52-week high
$8.57
52-week low
$2.24
Average daily volume
5.1m
Financial strength
Current ratio
6.589
Quick ratio
6.276
Long term debt to equity
1.247
Total debt to equity
2.567
Interest coverage (TTM)
-863.75%
Profitability
EBITDA (TTM)
-116.437
Gross margin (TTM)
-4,454.96%
Net profit margin (TTM)
-6,450.76%
Operating margin (TTM)
-6,962.69%
Effective tax rate (TTM)
-0.08%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-37.33%
Return on equity (TTM)
-63.89%
Valuation
Price to revenue (TTM)
658.41
Price to book
7.59
Price to tangible book (TTM)
9.95
Price to free cash flow (TTM)
-12.271
Free cash flow yield (TTM)
-8.15%
Free cash flow per share (TTM)
-0.685
Growth
Revenue change (TTM)
-61.87%
Earnings per share change (TTM)
-10.78%
3-year revenue growth (CAGR)
-33.34%
3-year earnings per share growth (CAGR)
-8.76%
What the Analysts think about Absci
Analyst ratings (Buy, Hold, Sell) for Absci stock.
Absci Financial Performance
Revenues and expenses
Absci Earnings Performance
Company profitability
Absci News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs